A randomized control trial of a psychosocial intervention for caregivers of allogeneic hematopoietic stem cell transplant patients: effects on distress.
M L Laudenslager, T L Simoneau, K Kilbourn...
https://pubmed.ncbi.nlm.nih.gov/25961767Actively Recruiting
Phase Not Applicable
Age: 18Years +
All Genders
ID07116018
Feasibility Testing of an Adapted Psychoeducational Intervention for Caregivers of Patients Undergoing Allogeneic Stem Cell Transplant for Hematological Malignancy
Led by University Health Network, Toronto · Updated on 2025-08-11
22
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Caregivers of patients undergoing allogeneic hematopoietic cell transplantation (alloHCT) for blood cancers face many challenges that can affect their well-being. Researchers are evaluating an adapted psychoeducational intervention designed to support these caregivers by teaching stress and energy management, coping skills, goal-setting, communication, and how to access support resources. This study aims to assess the feasibility, acceptability, and initial impact of this intervention. The intervention includes eight individual sessions delivered over 12 weeks via Microsoft Teams by a nurse facilitator. It is an adapted version of a previous psychoeducation program without the biofeedback part. Participants will start the intervention between the day of transplant and up to two weeks after. The sessions focus on practical exercises to help caregivers manage their stress and caregiving responsibilities. Participants will complete questionnaires at three times: before the intervention starts, one month after transplant, and three months after transplant. These will measure feasibility, acceptability, depression, anxiety, satisfaction with caregiving, and quality of life. The study will monitor how well participants engage with the program and their responses over time. The total participation period covers at least three months post-transplant.
CONDITIONS
Brief Title
Psychoeducation for AlloHCT Caregivers
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Must be caregiver for an adult patient diagnosed with hematological malignancy who is scheduled to receive allogeneic stem cell transplant.
- Recruited and consented during the patient's pre-transplant screening phase.
- Will provide care from the day of transplant up to 100 days post-transplant.
- Willing to begin the intervention no earlier than the day of transplant and no later than 2 weeks post-transplant.
You will not qualify if you...
- Younger than 18 years of age.
- Non-English speaking.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Outpatient Treatment
Duration - 12 weeks
Participants receive a psychoeducational program comprising 8 individual sessions delivered by a trained nurse over a 12 week period.
8 individual sessions
Trial Site Locations
Total: 1 location
1
Princess Margaret Cancer Centre, University Health Network
Toronto, Ontario, Canada, M5G 2M9
Actively Recruiting
Loading map...
Research Team
S
Samantha Mayo, RN, PhD
G
Grace Kusi, RN, PhD candidate
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here